{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:23:54Z","timestamp":1770881034987,"version":"3.50.1"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T00:00:00Z","timestamp":1414713600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0108780","type":"journal-article","created":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T17:52:41Z","timestamp":1414777961000},"page":"e108780","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Complex Impacts of PI3K\/AKT Inhibitors to Androgen Receptor Gene Expression in Prostate Cancer Cells"],"prefix":"10.1371","volume":"9","author":[{"given":"Liangliang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,10,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ejca.2013.12.004","article-title":"Molecular alterations and emerging targets in castration resistant prostate cancer","volume":"50","author":"D Lorente","year":"2014","journal-title":"Eur J Cancer"},{"key":"ref2","first-page":"3068","article-title":"Distant metastases from prostatic carcinoma express androgen receptor protein","volume":"55","author":"A Hobisch","year":"1995","journal-title":"Cancer Res"},{"key":"ref3","first-page":"2892","article-title":"Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen","volume":"61","author":"CW Gregory","year":"2001","journal-title":"Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng0495-401","article-title":"In vivo amplification of the androgen receptor gene and progression of human prostate cancer","volume":"9","author":"T Visakorpi","year":"1995","journal-title":"Nat Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1200\/JCO.2005.03.4777","article-title":"Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis","volume":"23","author":"HI Scher","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/01.ju.0000075099.20662.7f","article-title":"Androgen receptors in prostate cancer","volume":"170","author":"Z Culig","year":"2003","journal-title":"J Urol"},{"key":"ref7","first-page":"944","article-title":"Androgen receptor mutations in prostate cancer","volume":"60","author":"M Marcelli","year":"2000","journal-title":"Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1097\/01.ju.0000091873.09677.f4","article-title":"Androgen receptor gene amplification and protein expression in recurrent prostate cancer","volume":"170","author":"OH Ford 3rd","year":"2003","journal-title":"J Urol"},{"key":"ref9","first-page":"3550","article-title":"Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer","volume":"61","author":"MJ Linja","year":"2001","journal-title":"Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jsbmb.2004.10.003","article-title":"Expression and function of androgen receptor coactivators in prostate cancer","volume":"92","author":"Z Culig","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1158\/0008-5472.CAN-06-2836","article-title":"Androgen deprivation increases p300 expression in prostate cancer cells","volume":"67","author":"HV Heemers","year":"2007","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ijc.22365","article-title":"Androgen receptor coregulators and their involvement in the development and progression of prostate cancer","volume":"120","author":"R Chmelar","year":"2007","journal-title":"Int J Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","article-title":"A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth","volume":"69","author":"Z Guo","year":"2009","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/0008-5472.CAN-08-2764","article-title":"Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer","volume":"69","author":"R Hu","year":"2009","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1172\/JCI41824","article-title":"Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant","volume":"120","author":"S Sun","year":"2010","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/pros.21382","article-title":"A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities","volume":"71","author":"R Hu","year":"2011","journal-title":"Prostate"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"16759","DOI":"10.1073\/pnas.1012443107","article-title":"Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor","volume":"107","author":"PA Watson","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e19059","DOI":"10.1371\/journal.pone.0019059","article-title":"Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival","volume":"6","author":"E Hornberg","year":"2011","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"BS Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1530\/ERC-12-0394","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in castration-resistant prostate cancer","volume":"20","author":"RL Bitting","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ccr.2011.05.006","article-title":"Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth","volume":"19","author":"DJ Mulholland","year":"2011","journal-title":"Cancer Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2011.04.008","article-title":"Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer","volume":"19","author":"BS Carver","year":"2011","journal-title":"Cancer Cell"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"SP Davies","year":"2000","journal-title":"Biochem J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1074\/jbc.M413155200","article-title":"Pim-1 ligand-bound structures reveal the mechanism of serine\/threonine kinase inhibition by LY294002","volume":"280","author":"MD Jacobs","year":"2005","journal-title":"J Biol Chem"},{"key":"ref25","first-page":"3065","article-title":"Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer","volume":"118","author":"A Carracedo","year":"2008","journal-title":"J Clin Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"KE O'Reilly","year":"2006","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/onc.2013.284","article-title":"Mechanisms of the androgen receptor splicing in prostate cancer cells","volume":"33","author":"LL Liu","year":"2014","journal-title":"Oncogene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1158\/0008-5472.CAN-11-3892","article-title":"Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer","volume":"72","author":"R Hu","year":"2012","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1210\/jc.2012-4000","article-title":"Expression and function of the progesterone receptor in human prostate stroma provide novel insights to cell proliferation control","volume":"98","author":"Y Yu","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e92714","DOI":"10.1371\/journal.pone.0092714","article-title":"Prostate stromal cells express the progesterone receptor to control cancer cell mobility","volume":"9","author":"Y Yu","year":"2014","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1210\/jc.2012-2451","article-title":"Proliferative action of the androgen receptor in human uterine myometrial cells\u2013a key regulator for myometrium phenotype programming","volume":"98","author":"L Liu","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"16967","DOI":"10.1073\/pnas.0503853102","article-title":"Regulation of endothelial nitric oxide synthase by small RNA","volume":"102","author":"MX Zhang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1016\/S0021-9258(17)37680-9","article-title":"A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002)","volume":"269","author":"CJ Vlahos","year":"1994","journal-title":"J Biol Chem"},{"issue":"(Pt 2)","key":"ref34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj2960297","article-title":"Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses","volume":"296","author":"A Arcaro","year":"1993","journal-title":"Biochem J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/ml200156t","article-title":"Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer","volume":"2","author":"MT Burger","year":"2011","journal-title":"ACS Med Chem Lett"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1021\/jm000117y","article-title":"3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth","volume":"43","author":"Y Hu","year":"2000","journal-title":"J Med Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1021\/jm301762v","article-title":"Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin -4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases","volume":"56","author":"M Addie","year":"2013","journal-title":"J Med Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/1535-7163.MCT-11-0824-T","article-title":"Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background","volume":"11","author":"BR Davies","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1101\/gr.131508.111","article-title":"Cooperation between Polycomb and androgen receptor during oncogenic transformation","volume":"22","author":"JC Zhao","year":"2012","journal-title":"Genome Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1073\/pnas.0304146101","article-title":"Gene expression profiling identifies clinically relevant subtypes of prostate cancer","volume":"101","author":"J Lapointe","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","first-page":"204","article-title":"Interfocal heterogeneity of PTEN\/MMAC1 gene alterations in multiple metastatic prostate cancer tissues","volume":"58","author":"H Suzuki","year":"1998","journal-title":"Cancer Res"},{"key":"ref42","article-title":"Androgen Deprivation Induces Phenotypic Plasticity and Promotes Resistance to Molecular Targeted Therapy in a PTEN-deficient Mouse Model of Prostate Cancer","author":"MA De Velasco","year":"2014","journal-title":"Carcinogenesis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0108780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:44:29Z","timestamp":1650501869000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0108780"}},"subtitle":[],"editor":[{"given":"Irina U.","family":"Agoulnik","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,31]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0108780","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,31]]}}}